Disruption and maturity: the future directions for biologics in healthcare

Presented by

Paul Tunnah (moderator), Angela McFarlane, Sarah Rickwood, Margaret Dolan and Timothy C. de Gavre

About this talk

A digital debate analysing the future for biologics in the UK and the factor affecting market access in this territory. Our expert panel will cover a number of key topics including: •Are the savings offered by biosimilars being used to innovate and take advantage of the exciting new biologic technologies or just filling in the NHS potholes? •Will the industry continue to invest in cutting-edge research if the UK is not prepared to fund access to it •In a post-Brexit world how can the UK continue to be a global leader at the cutting edge of biologics research?

Related topics:

More from this channel

Upcoming talks (2)
On-demand talks (104)
Subscribers (26361)
pharmaphorum provides a digital podium for communicating thought leadership and innovation within pharma. Our webinars bring together different stakeholders from across the healthcare spectrum to drive fresh thinking and novel solutions that deliver better outcomes for patients.